AKT1 and nasopharyngeal carcinoma: In 2018, Lu et al. [171] reported that, in nasopharyngeal carcinoma (NPC), exosomal miR-9 inhibited angiogenesis by targeting the heparin-binding growth factor Midkine (MDK) and regulating the PDK/AKT signaling pathway.